Khoi H Tran
Supervisory Patent Examiner (ID: 6826, Phone: (571)272-6919 , Office: P/3664 )
Most Active Art Unit | 3651 |
Art Unit(s) | 3101, 3664, 3615, 3651 |
Total Applications | 1154 |
Issued Applications | 874 |
Pending Applications | 133 |
Abandoned Applications | 147 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14749101
[patent_doc_number] => 20190257724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Functional Targeted Brain Endoskeletonization
[patent_app_type] => utility
[patent_app_number] => 16/151057
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16151057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/151057 | Functional Targeted Brain Endoskeletonization | Oct 2, 2018 | Abandoned |
Array
(
[id] => 16328720
[patent_doc_number] => 20200299686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity
[patent_app_type] => utility
[patent_app_number] => 16/652905
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652905 | Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity | Oct 1, 2018 | Pending |
Array
(
[id] => 16839793
[patent_doc_number] => 20210147805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => IN VITRO METHOD FOR PROVIDING STEM CELL DERIVED CARDIOMYOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/649475
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16649475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/649475 | IN VITRO METHOD FOR PROVIDING STEM CELL DERIVED CARDIOMYOCYTES | Sep 20, 2018 | Abandoned |
Array
(
[id] => 17734991
[patent_doc_number] => 20220220450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => FABRICATION OF A BIOMIMETIC PLATFORM SYSTEM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/648186
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648186 | FABRICATION OF A BIOMIMETIC PLATFORM SYSTEM AND METHODS OF USE | Sep 17, 2018 | Pending |
Array
(
[id] => 15408477
[patent_doc_number] => 20200024560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => Additive Manufacturing of Functional Myocardial Tissue
[patent_app_type] => utility
[patent_app_number] => 16/119022
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119022 | Additive manufacturing of functional myocardial tissue | Aug 30, 2018 | Issued |
Array
(
[id] => 13931893
[patent_doc_number] => 20190049462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/118304
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118304 | LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF | Aug 29, 2018 | Abandoned |
Array
(
[id] => 14409771
[patent_doc_number] => 20190170729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/108420
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16108420
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/108420 | REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF | Aug 21, 2018 | Abandoned |
Array
(
[id] => 13987077
[patent_doc_number] => 20190062696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/109218
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109218 | Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells | Aug 21, 2018 | Issued |
Array
(
[id] => 13902301
[patent_doc_number] => 20190040355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => A method of cryopreserving an amniotic membrane of a placenta tissue sample
[patent_app_type] => utility
[patent_app_number] => 16/100593
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100593 | Obtaining multipotent amnion-derived stem cell (ADSC) from amniotic membrane tissue without enzymatic digestion | Aug 9, 2018 | Issued |
Array
(
[id] => 13622223
[patent_doc_number] => 20180362663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => ADAM6 MICE
[patent_app_type] => utility
[patent_app_number] => 16/059821
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059821 | ADAM6 mice | Aug 8, 2018 | Issued |
Array
(
[id] => 13590099
[patent_doc_number] => 20180346598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => ADAM6 MICE
[patent_app_type] => utility
[patent_app_number] => 16/059871
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059871 | ADAM6 mice | Aug 8, 2018 | Issued |
Array
(
[id] => 13588423
[patent_doc_number] => 20180345760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => ADAM6 MICE
[patent_app_type] => utility
[patent_app_number] => 16/059884
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059884
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059884 | ADAM6 mice | Aug 8, 2018 | Issued |
Array
(
[id] => 13590101
[patent_doc_number] => 20180346599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => ADAM6 MICE
[patent_app_type] => utility
[patent_app_number] => 16/059922
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059922
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059922 | ADAM6 mice | Aug 8, 2018 | Issued |
Array
(
[id] => 16112189
[patent_doc_number] => 20200208117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => A RELIABLE AND REPRODUCIBLE INDUSTRIALISATION PROCESS FOR THE ELIMINATION OF AIR BUBBLES IN THE PRODUCTION OF AN ENGINEERED VASCULAR TISSUE
[patent_app_type] => utility
[patent_app_number] => 16/639090
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639090 | A RELIABLE AND REPRODUCIBLE INDUSTRIALISATION PROCESS FOR THE ELIMINATION OF AIR BUBBLES IN THE PRODUCTION OF AN ENGINEERED VASCULAR TISSUE | Aug 6, 2018 | Abandoned |
Array
(
[id] => 17267693
[patent_doc_number] => 11193108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Single cells pluripotent stem cells in a suspension culture
[patent_app_type] => utility
[patent_app_number] => 16/055110
[patent_app_country] => US
[patent_app_date] => 2018-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 62
[patent_no_of_words] => 35630
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16055110
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/055110 | Single cells pluripotent stem cells in a suspension culture | Aug 4, 2018 | Issued |
Array
(
[id] => 16009449
[patent_doc_number] => 20200179567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => REGIONALLY SPECIFIC TISSUE-DERIVED EXTRACELLULAR MATRIX
[patent_app_type] => utility
[patent_app_number] => 16/054162
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054162 | REGIONALLY SPECIFIC TISSUE-DERIVED EXTRACELLULAR MATRIX | Aug 2, 2018 | Abandoned |
Array
(
[id] => 14680759
[patent_doc_number] => 20190239494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => ANIMAL MODEL OF BRAIN TUMOR AND MANUFACTURING METHOD OF ANIMAL MODEL
[patent_app_type] => utility
[patent_app_number] => 16/050006
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16050006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/050006 | Animal model of brain tumor and manufacturing method of animal model | Jul 30, 2018 | Issued |
Array
(
[id] => 13987107
[patent_doc_number] => 20190062711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Use Of Phosphorylated TBeta4 And Other Factors To Generate Human Induced Pluripotent Stem Cells
[patent_app_type] => utility
[patent_app_number] => 16/044142
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044142 | Use Of Phosphorylated TBeta4 And Other Factors To Generate Human Induced Pluripotent Stem Cells | Jul 23, 2018 | Pending |
Array
(
[id] => 13554793
[patent_doc_number] => 20180328944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/039176
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039176 | Light-activated cation channel and uses thereof | Jul 17, 2018 | Issued |
Array
(
[id] => 13793317
[patent_doc_number] => 20190010197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD USING EXPRESSION OF LIN28 FOR PREPARING STEM CELLS HAVING EXCELLENT RENEWAL ABILITY AND THERAPEUTIC CAPACITY
[patent_app_type] => utility
[patent_app_number] => 16/035318
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035318 | Method using expression of LIN28 for preparing stem cells having excellent renewal ability and therapeutic capacity | Jul 12, 2018 | Issued |